

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tooth mineralization (GO:0034505) | 8.67416055 |
| 2 | resolution of meiotic recombination intermediates (GO:0000712) | 7.90252654 |
| 3 | quaternary ammonium group transport (GO:0015697) | 7.77847184 |
| 4 | drug transmembrane transport (GO:0006855) | 7.66551172 |
| 5 | neurotransmitter biosynthetic process (GO:0042136) | 7.54952605 |
| 6 | organic cation transport (GO:0015695) | 7.45469152 |
| 7 | positive regulation of meiosis (GO:0045836) | 6.67804098 |
| 8 | bone trabecula formation (GO:0060346) | 6.66911167 |
| 9 | exogenous drug catabolic process (GO:0042738) | 6.46959255 |
| 10 | neurotransmitter metabolic process (GO:0042133) | 6.43409813 |
| 11 | fatty acid elongation (GO:0030497) | 6.27503094 |
| 12 | positive regulation of meiotic cell cycle (GO:0051446) | 6.20493789 |
| 13 | azole transport (GO:0045117) | 5.78116400 |
| 14 | positive regulation of immune response to tumor cell (GO:0002839) | 5.68216205 |
| 15 | regulation of immune response to tumor cell (GO:0002837) | 5.68216205 |
| 16 | regulation of response to tumor cell (GO:0002834) | 5.68216205 |
| 17 | positive regulation of response to tumor cell (GO:0002836) | 5.68216205 |
| 18 | synaptonemal complex assembly (GO:0007130) | 5.54301899 |
| 19 | histone H3-K36 demethylation (GO:0070544) | 5.49861116 |
| 20 | histone-serine phosphorylation (GO:0035404) | 5.47122428 |
| 21 | drug transport (GO:0015893) | 5.35117864 |
| 22 | positive regulation of hair cycle (GO:0042635) | 5.28835820 |
| 23 | positive regulation of hair follicle development (GO:0051798) | 5.28835820 |
| 24 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 5.10936803 |
| 25 | synaptonemal complex organization (GO:0070193) | 4.98466801 |
| 26 | drug catabolic process (GO:0042737) | 4.98423922 |
| 27 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 4.90363246 |
| 28 | positive regulation of protein homodimerization activity (GO:0090073) | 4.82576144 |
| 29 | reciprocal meiotic recombination (GO:0007131) | 4.75146408 |
| 30 | reciprocal DNA recombination (GO:0035825) | 4.75146408 |
| 31 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.60534586 |
| 32 | rRNA catabolic process (GO:0016075) | 4.57532373 |
| 33 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 4.47379594 |
| 34 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 4.43938466 |
| 35 | fatty acid transmembrane transport (GO:1902001) | 4.42296455 |
| 36 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.41236658 |
| 37 | cranial suture morphogenesis (GO:0060363) | 4.38455427 |
| 38 | negative regulation of telomere maintenance (GO:0032205) | 4.30715987 |
| 39 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 4.29736735 |
| 40 | regulation of meiosis I (GO:0060631) | 4.26341389 |
| 41 | wound healing, spreading of epidermal cells (GO:0035313) | 4.24341959 |
| 42 | carnitine shuttle (GO:0006853) | 4.19939868 |
| 43 | behavioral response to nicotine (GO:0035095) | 4.16664572 |
| 44 | endothelium development (GO:0003158) | 4.13625926 |
| 45 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 4.07135026 |
| 46 | protein neddylation (GO:0045116) | 3.98501236 |
| 47 | chromosome organization involved in meiosis (GO:0070192) | 3.92261694 |
| 48 | positive regulation of mast cell activation (GO:0033005) | 3.91144366 |
| 49 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.90936836 |
| 50 | L-phenylalanine catabolic process (GO:0006559) | 3.82112951 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.82112951 |
| 52 | histone phosphorylation (GO:0016572) | 3.61115488 |
| 53 | * detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.56835295 |
| 54 | arginine catabolic process (GO:0006527) | 3.54667091 |
| 55 | tyrosine metabolic process (GO:0006570) | 3.51668171 |
| 56 | negative regulation by host of viral transcription (GO:0043922) | 3.46649508 |
| 57 | regulation of hair follicle development (GO:0051797) | 3.38253486 |
| 58 | protein K6-linked ubiquitination (GO:0085020) | 3.37088218 |
| 59 | regulation of energy homeostasis (GO:2000505) | 3.35862227 |
| 60 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.35511250 |
| 61 | C4-dicarboxylate transport (GO:0015740) | 3.31264554 |
| 62 | secretory granule organization (GO:0033363) | 3.27030301 |
| 63 | negative regulation of epidermis development (GO:0045683) | 3.22359780 |
| 64 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 3.21695052 |
| 65 | outflow tract septum morphogenesis (GO:0003148) | 3.14612253 |
| 66 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.13875602 |
| 67 | L-phenylalanine metabolic process (GO:0006558) | 3.13875602 |
| 68 | regulation of hippo signaling (GO:0035330) | 3.12615925 |
| 69 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.09087557 |
| 70 | carnitine transmembrane transport (GO:1902603) | 3.08218876 |
| 71 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.03381731 |
| 72 | regulation of activation of Janus kinase activity (GO:0010533) | 3.00852881 |
| 73 | trabecula formation (GO:0060343) | 3.00730251 |
| 74 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.00701291 |
| 75 | activin receptor signaling pathway (GO:0032924) | 2.96477066 |
| 76 | aromatic amino acid family catabolic process (GO:0009074) | 2.89127496 |
| 77 | retinal cone cell development (GO:0046549) | 2.88359006 |
| 78 | thrombin receptor signaling pathway (GO:0070493) | 2.86045397 |
| 79 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.83167598 |
| 80 | carnitine transport (GO:0015879) | 2.82608490 |
| 81 | amino-acid betaine transport (GO:0015838) | 2.82608490 |
| 82 | negative regulation of neurotransmitter transport (GO:0051589) | 2.80196440 |
| 83 | cellular response to estradiol stimulus (GO:0071392) | 2.79962915 |
| 84 | regulation of meiosis (GO:0040020) | 2.78604650 |
| 85 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.78239704 |
| 86 | negative regulation of TOR signaling (GO:0032007) | 2.78124038 |
| 87 | lysosome localization (GO:0032418) | 2.74288681 |
| 88 | nephron epithelium morphogenesis (GO:0072088) | 2.72884806 |
| 89 | nephron tubule morphogenesis (GO:0072078) | 2.72884806 |
| 90 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.69517332 |
| 91 | synapsis (GO:0007129) | 2.68824303 |
| 92 | rRNA methylation (GO:0031167) | 2.66969467 |
| 93 | * detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.66881173 |
| 94 | positive regulation by host of viral transcription (GO:0043923) | 2.66188065 |
| 95 | dopamine transport (GO:0015872) | 2.63729455 |
| 96 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.61822329 |
| 97 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.59567640 |
| 98 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.58941903 |
| 99 | histamine transport (GO:0051608) | 10.3210866 |
| 100 | meiotic chromosome segregation (GO:0045132) | 10.0796981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 9.00914408 |
| 2 | IRF1_19129219_ChIP-ChIP_H3396_Human | 3.79099938 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.62097225 |
| 4 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.69252511 |
| 5 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.56105067 |
| 6 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 2.42217962 |
| 7 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.42165938 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.33646148 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.33182761 |
| 10 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06723889 |
| 11 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.05662094 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.94066083 |
| 13 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.89419912 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86119537 |
| 15 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.79593361 |
| 16 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.79593361 |
| 17 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.74761325 |
| 18 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.73061761 |
| 19 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.68326680 |
| 20 | EWS_26573619_Chip-Seq_HEK293_Human | 1.63222517 |
| 21 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63118138 |
| 22 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.57070164 |
| 23 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.51737772 |
| 24 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.49387183 |
| 25 | * OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.49155072 |
| 26 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.46983788 |
| 27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.45114488 |
| 28 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43385615 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.43377991 |
| 30 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.40375365 |
| 31 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.39323202 |
| 32 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39313716 |
| 33 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.37688755 |
| 34 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37688755 |
| 35 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.36606925 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.35463245 |
| 37 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34262900 |
| 38 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.33530577 |
| 39 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.32920115 |
| 40 | JUN_21703547_ChIP-Seq_K562_Human | 1.32691106 |
| 41 | TCF4_23295773_ChIP-Seq_U87_Human | 1.32309662 |
| 42 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27450794 |
| 43 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25983983 |
| 44 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25004092 |
| 45 | GATA2_19941826_ChIP-Seq_K562_Human | 1.23417774 |
| 46 | AR_20517297_ChIP-Seq_VCAP_Human | 1.22744770 |
| 47 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.22624733 |
| 48 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21545383 |
| 49 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.21454514 |
| 50 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.18671213 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16673082 |
| 52 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.16085822 |
| 53 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.14102814 |
| 54 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.13814576 |
| 55 | GATA3_26560356_Chip-Seq_TH1_Human | 1.13216275 |
| 56 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12751300 |
| 57 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12557865 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.11876783 |
| 59 | P300_27268052_Chip-Seq_Bcells_Human | 1.11858409 |
| 60 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11528455 |
| 61 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11084695 |
| 62 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.10820108 |
| 63 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.09665881 |
| 64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08240724 |
| 65 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.06056262 |
| 66 | * BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 1.05815378 |
| 67 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.05616394 |
| 68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05448122 |
| 69 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.04578608 |
| 70 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.01566142 |
| 71 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.00602669 |
| 72 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.99784595 |
| 73 | ERA_21632823_ChIP-Seq_H3396_Human | 0.99686230 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99335398 |
| 75 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.99135802 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98985046 |
| 77 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98655984 |
| 78 | NCOR_22424771_ChIP-Seq_293T_Human | 0.98564884 |
| 79 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.98529438 |
| 80 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.97141044 |
| 81 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96804067 |
| 82 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.96629772 |
| 83 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96314789 |
| 84 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.95975702 |
| 85 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94143955 |
| 86 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.93965591 |
| 87 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93742367 |
| 88 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.92092101 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92053848 |
| 90 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91551152 |
| 91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.91228125 |
| 92 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.90013151 |
| 93 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89562530 |
| 94 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.88985311 |
| 95 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.88453591 |
| 96 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87807018 |
| 97 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85104122 |
| 98 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84736480 |
| 99 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.84379109 |
| 100 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83825880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 6.50330829 |
| 2 | MP0003646_muscle_fatigue | 6.24786793 |
| 3 | MP0005167_abnormal_blood-brain_barrier | 3.70884248 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 2.99533354 |
| 5 | MP0004043_abnormal_pH_regulation | 2.86437705 |
| 6 | MP0005464_abnormal_platelet_physiology | 2.85490234 |
| 7 | MP0004130_abnormal_muscle_cell | 2.84151851 |
| 8 | MP0008872_abnormal_physiological_respon | 2.80202507 |
| 9 | MP0001919_abnormal_reproductive_system | 2.60324657 |
| 10 | MP0002160_abnormal_reproductive_system | 2.56937328 |
| 11 | MP0005645_abnormal_hypothalamus_physiol | 2.42857011 |
| 12 | MP0003136_yellow_coat_color | 2.41249768 |
| 13 | MP0004084_abnormal_cardiac_muscle | 2.33116860 |
| 14 | MP0004381_abnormal_hair_follicle | 2.28578304 |
| 15 | MP0003329_amyloid_beta_deposits | 2.24117731 |
| 16 | MP0005410_abnormal_fertilization | 2.13814530 |
| 17 | MP0008004_abnormal_stomach_pH | 2.12073815 |
| 18 | MP0001873_stomach_inflammation | 2.09408861 |
| 19 | MP0005389_reproductive_system_phenotype | 1.95289872 |
| 20 | MP0002163_abnormal_gland_morphology | 1.95035260 |
| 21 | MP0004147_increased_porphyrin_level | 1.90899529 |
| 22 | MP0000372_irregular_coat_pigmentation | 1.83487590 |
| 23 | MP0008775_abnormal_heart_ventricle | 1.82749559 |
| 24 | MP0010329_abnormal_lipoprotein_level | 1.76804631 |
| 25 | MP0005647_abnormal_sex_gland | 1.74654617 |
| 26 | MP0001440_abnormal_grooming_behavior | 1.66427934 |
| 27 | MP0006276_abnormal_autonomic_nervous | 1.66103733 |
| 28 | MP0002139_abnormal_hepatobiliary_system | 1.63899011 |
| 29 | MP0003045_fibrosis | 1.60117293 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.58449099 |
| 31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.53936413 |
| 32 | MP0005085_abnormal_gallbladder_physiolo | 1.53683027 |
| 33 | MP0004858_abnormal_nervous_system | 1.49141631 |
| 34 | MP0001664_abnormal_digestion | 1.46658694 |
| 35 | MP0003195_calcinosis | 1.41843148 |
| 36 | MP0005266_abnormal_metabolism | 1.37298263 |
| 37 | MP0004233_abnormal_muscle_weight | 1.37189554 |
| 38 | MP0008877_abnormal_DNA_methylation | 1.32879052 |
| 39 | MP0005084_abnormal_gallbladder_morpholo | 1.29327697 |
| 40 | MP0005551_abnormal_eye_electrophysiolog | 1.27919630 |
| 41 | MP0002733_abnormal_thermal_nociception | 1.27176733 |
| 42 | MP0004484_altered_response_of | 1.25440738 |
| 43 | MP0004883_abnormal_blood_vessel | 1.23254393 |
| 44 | MP0003718_maternal_effect | 1.13561743 |
| 45 | MP0005365_abnormal_bile_salt | 1.11454637 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.11262577 |
| 47 | MP0006054_spinal_hemorrhage | 1.10500989 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.06558702 |
| 49 | MP0002210_abnormal_sex_determination | 1.05351444 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 1.02874748 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.01040513 |
| 52 | MP0000049_abnormal_middle_ear | 0.99537928 |
| 53 | MP0009643_abnormal_urine_homeostasis | 0.98145888 |
| 54 | MP0000470_abnormal_stomach_morphology | 0.96698374 |
| 55 | MP0005448_abnormal_energy_balance | 0.95768056 |
| 56 | MP0000230_abnormal_systemic_arterial | 0.95726852 |
| 57 | MP0001879_abnormal_lymphatic_vessel | 0.92331715 |
| 58 | MP0005360_urolithiasis | 0.91607203 |
| 59 | MP0009745_abnormal_behavioral_response | 0.91227783 |
| 60 | MP0002876_abnormal_thyroid_physiology | 0.91076358 |
| 61 | MP0000427_abnormal_hair_cycle | 0.90687843 |
| 62 | MP0004036_abnormal_muscle_relaxation | 0.89964706 |
| 63 | MP0003698_abnormal_male_reproductive | 0.89869771 |
| 64 | MP0003252_abnormal_bile_duct | 0.89134877 |
| 65 | MP0001663_abnormal_digestive_system | 0.88723732 |
| 66 | MP0001968_abnormal_touch/_nociception | 0.87819509 |
| 67 | MP0000604_amyloidosis | 0.84303143 |
| 68 | MP0003632_abnormal_nervous_system | 0.84157866 |
| 69 | MP0001790_abnormal_immune_system | 0.83722578 |
| 70 | MP0005387_immune_system_phenotype | 0.83722578 |
| 71 | MP0003186_abnormal_redox_activity | 0.83117975 |
| 72 | MP0010307_abnormal_tumor_latency | 0.81622139 |
| 73 | MP0003638_abnormal_response/metabolism_ | 0.79891561 |
| 74 | MP0000858_altered_metastatic_potential | 0.78410387 |
| 75 | MP0004142_abnormal_muscle_tone | 0.76822310 |
| 76 | MP0002148_abnormal_hypersensitivity_rea | 0.74882223 |
| 77 | MP0002557_abnormal_social/conspecific_i | 0.74234599 |
| 78 | MP0004134_abnormal_chest_morphology | 0.73704050 |
| 79 | MP0003693_abnormal_embryo_hatching | 0.73266598 |
| 80 | MP0009697_abnormal_copulation | 0.73013395 |
| 81 | MP0006138_congestive_heart_failure | 0.72825776 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 0.72473303 |
| 83 | MP0004215_abnormal_myocardial_fiber | 0.69020502 |
| 84 | MP0005646_abnormal_pituitary_gland | 0.68152254 |
| 85 | MP0001970_abnormal_pain_threshold | 0.67324011 |
| 86 | MP0005332_abnormal_amino_acid | 0.66636784 |
| 87 | MP0001286_abnormal_eye_development | 0.66176102 |
| 88 | MP0000747_muscle_weakness | 0.65670506 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.65261042 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.64635360 |
| 91 | MP0001929_abnormal_gametogenesis | 0.64216748 |
| 92 | MP0001145_abnormal_male_reproductive | 0.64216582 |
| 93 | MP0005671_abnormal_response_to | 0.61094517 |
| 94 | MP0000653_abnormal_sex_gland | 0.59223898 |
| 95 | MP0001346_abnormal_lacrimal_gland | 0.59164066 |
| 96 | MP0010368_abnormal_lymphatic_system | 0.59066925 |
| 97 | MP0009764_decreased_sensitivity_to | 0.58874031 |
| 98 | MP0002089_abnormal_postnatal_growth/wei | 0.58454182 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.57296485 |
| 100 | MP0002132_abnormal_respiratory_system | 0.57012423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Unilateral renal agenesis (HP:0000122) | 9.41434314 |
| 2 | Hypoplasia of the fovea (HP:0007750) | 8.05658991 |
| 3 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 8.05658991 |
| 4 | Bilateral microphthalmos (HP:0007633) | 7.36347799 |
| 5 | Conjugated hyperbilirubinemia (HP:0002908) | 6.90924756 |
| 6 | Abnormality of the fovea (HP:0000493) | 6.45702649 |
| 7 | Aplasia cutis congenita (HP:0001057) | 5.69048215 |
| 8 | Fused cervical vertebrae (HP:0002949) | 5.26381273 |
| 9 | Aplasia/Hypoplasia of the macula (HP:0008059) | 5.25619438 |
| 10 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 4.90880628 |
| 11 | Abnormality of the right ventricle (HP:0001707) | 4.77721787 |
| 12 | Abnormality of the parietal bone (HP:0002696) | 4.52177762 |
| 13 | Progressive inability to walk (HP:0002505) | 4.48861890 |
| 14 | 3-Methylglutaconic aciduria (HP:0003535) | 4.20355885 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 4.14576912 |
| 16 | Widely patent fontanelles and sutures (HP:0004492) | 4.09120287 |
| 17 | Abnormality of transition element cation homeostasis (HP:0011030) | 4.08309184 |
| 18 | Mixed hearing impairment (HP:0000410) | 3.93542846 |
| 19 | Central scotoma (HP:0000603) | 3.70452747 |
| 20 | Prolonged bleeding time (HP:0003010) | 3.42654114 |
| 21 | Congenital stationary night blindness (HP:0007642) | 3.31650077 |
| 22 | Decreased central vision (HP:0007663) | 3.30050322 |
| 23 | Menorrhagia (HP:0000132) | 3.29171150 |
| 24 | Concave nail (HP:0001598) | 3.19012731 |
| 25 | Lissencephaly (HP:0001339) | 3.18750359 |
| 26 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 3.15729807 |
| 27 | CNS hypomyelination (HP:0003429) | 3.07382058 |
| 28 | Inability to walk (HP:0002540) | 3.04185379 |
| 29 | Abnormality of iron homeostasis (HP:0011031) | 3.00266408 |
| 30 | Lower limb hyperreflexia (HP:0002395) | 2.80961288 |
| 31 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.63346446 |
| 32 | Hip dysplasia (HP:0001385) | 2.59037288 |
| 33 | Posterior subcapsular cataract (HP:0007787) | 2.56258173 |
| 34 | Tubular atrophy (HP:0000092) | 2.52390949 |
| 35 | Vertebral fusion (HP:0002948) | 2.43381472 |
| 36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.39735346 |
| 37 | Increased mean platelet volume (HP:0011877) | 2.37351143 |
| 38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.35051209 |
| 39 | Sensorimotor neuropathy (HP:0007141) | 2.33758052 |
| 40 | Clitoromegaly (HP:0000057) | 2.26893135 |
| 41 | Ulnar deviation of the wrist (HP:0003049) | 2.25007048 |
| 42 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.22553352 |
| 43 | Attenuation of retinal blood vessels (HP:0007843) | 2.21760118 |
| 44 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.21317777 |
| 45 | Wide cranial sutures (HP:0010537) | 2.19091932 |
| 46 | Arthropathy (HP:0003040) | 2.18882237 |
| 47 | Metabolic alkalosis (HP:0200114) | 2.17600182 |
| 48 | Brushfield spots (HP:0001088) | 2.15624059 |
| 49 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.12141619 |
| 50 | Bulbous nose (HP:0000414) | 2.11939048 |
| 51 | Stomatitis (HP:0010280) | 2.11012035 |
| 52 | Abnormal platelet volume (HP:0011876) | 2.10225950 |
| 53 | Scotoma (HP:0000575) | 2.07561352 |
| 54 | Increased serum ferritin (HP:0003281) | 2.00292326 |
| 55 | Abnormality of proline metabolism (HP:0010907) | 1.97687482 |
| 56 | Hydroxyprolinuria (HP:0003080) | 1.97687482 |
| 57 | Gaze-evoked nystagmus (HP:0000640) | 1.97211231 |
| 58 | Sprengel anomaly (HP:0000912) | 1.96468796 |
| 59 | Renal tubular acidosis (HP:0001947) | 1.96361569 |
| 60 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.93547367 |
| 61 | Abnormality of midbrain morphology (HP:0002418) | 1.92257237 |
| 62 | Molar tooth sign on MRI (HP:0002419) | 1.92257237 |
| 63 | Tetraplegia (HP:0002445) | 1.92067064 |
| 64 | Abnormality of the renal cortex (HP:0011035) | 1.91006477 |
| 65 | Epistaxis (HP:0000421) | 1.90149344 |
| 66 | Birth length less than 3rd percentile (HP:0003561) | 1.88743483 |
| 67 | Progressive cerebellar ataxia (HP:0002073) | 1.86535928 |
| 68 | Severe muscular hypotonia (HP:0006829) | 1.86413554 |
| 69 | Hyperglycinuria (HP:0003108) | 1.85021876 |
| 70 | Petechiae (HP:0000967) | 1.83716223 |
| 71 | Triphalangeal thumb (HP:0001199) | 1.83601626 |
| 72 | Conical tooth (HP:0000698) | 1.83580227 |
| 73 | Hypoplasia of the uterus (HP:0000013) | 1.81391881 |
| 74 | Increased cerebral lipofuscin (HP:0011813) | 1.80994745 |
| 75 | Abnormality of the clitoris (HP:0000056) | 1.77928252 |
| 76 | Constricted visual fields (HP:0001133) | 1.77870939 |
| 77 | Hyperbilirubinemia (HP:0002904) | 1.75553966 |
| 78 | Cerebral palsy (HP:0100021) | 1.75544224 |
| 79 | Febrile seizures (HP:0002373) | 1.74433835 |
| 80 | Premature skin wrinkling (HP:0100678) | 1.72446427 |
| 81 | Partial agenesis of the corpus callosum (HP:0001338) | 1.72391348 |
| 82 | Dysmetric saccades (HP:0000641) | 1.68694647 |
| 83 | Purpura (HP:0000979) | 1.68135567 |
| 84 | Abnormality of alanine metabolism (HP:0010916) | 1.68106514 |
| 85 | Hyperalaninemia (HP:0003348) | 1.68106514 |
| 86 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.68106514 |
| 87 | Multifactorial inheritance (HP:0001426) | 1.67750689 |
| 88 | Short clavicles (HP:0000894) | 1.66405617 |
| 89 | Hepatosplenomegaly (HP:0001433) | 1.64758836 |
| 90 | Autoimmune thrombocytopenia (HP:0001973) | 1.63712331 |
| 91 | Renal agenesis (HP:0000104) | 1.63193331 |
| 92 | Joint swelling (HP:0001386) | 1.63004608 |
| 93 | Prominent nose (HP:0000448) | 1.60592715 |
| 94 | Ectopic anus (HP:0004397) | 1.60340466 |
| 95 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.59885553 |
| 96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.59885553 |
| 97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.59885553 |
| 98 | Decreased circulating renin level (HP:0003351) | 1.55765507 |
| 99 | Xanthomatosis (HP:0000991) | 1.54348286 |
| 100 | Poikilocytosis (HP:0004447) | 1.53086755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 9.38190972 |
| 2 | BMPR2 | 5.57251061 |
| 3 | TLK1 | 4.71181046 |
| 4 | SIK3 | 3.70804387 |
| 5 | PINK1 | 3.30742413 |
| 6 | SIK2 | 3.20153949 |
| 7 | NEK2 | 2.34873312 |
| 8 | MAP3K7 | 2.26951141 |
| 9 | SIK1 | 2.26294420 |
| 10 | ADRBK2 | 2.03376443 |
| 11 | ERBB2 | 1.99142576 |
| 12 | MAP3K11 | 1.89157201 |
| 13 | ICK | 1.80324878 |
| 14 | MST4 | 1.68040772 |
| 15 | BTK | 1.64297226 |
| 16 | ACVR1B | 1.61366782 |
| 17 | STK11 | 1.57189149 |
| 18 | MARK3 | 1.52423755 |
| 19 | STK3 | 1.44521115 |
| 20 | TAOK3 | 1.39374587 |
| 21 | DAPK2 | 1.36158313 |
| 22 | MAPKAPK3 | 1.25213741 |
| 23 | TIE1 | 1.22674883 |
| 24 | MELK | 1.16353636 |
| 25 | FRK | 1.16291178 |
| 26 | PTK2B | 1.12376923 |
| 27 | TEC | 1.08193909 |
| 28 | PRKAA2 | 1.02929775 |
| 29 | EEF2K | 0.98065250 |
| 30 | BMPR1B | 0.92917198 |
| 31 | MAPKAPK5 | 0.92110153 |
| 32 | CAMK1 | 0.88286939 |
| 33 | SYK | 0.86219501 |
| 34 | ILK | 0.85461112 |
| 35 | STK38 | 0.83881621 |
| 36 | BMX | 0.83493355 |
| 37 | BCR | 0.78611566 |
| 38 | FLT3 | 0.74590417 |
| 39 | NUAK1 | 0.73778383 |
| 40 | TRPM7 | 0.72001791 |
| 41 | PRKAA1 | 0.68721287 |
| 42 | PRKCI | 0.67333837 |
| 43 | CDK12 | 0.62644153 |
| 44 | CAMK4 | 0.62260378 |
| 45 | ADRBK1 | 0.57185035 |
| 46 | GRK1 | 0.55561358 |
| 47 | IRAK1 | 0.52191028 |
| 48 | BRSK2 | 0.52030741 |
| 49 | GRK5 | 0.51555871 |
| 50 | MAP2K1 | 0.51460869 |
| 51 | CHEK2 | 0.50043882 |
| 52 | TXK | 0.47729278 |
| 53 | WNK3 | 0.46501945 |
| 54 | PRKCG | 0.43673116 |
| 55 | RPS6KA6 | 0.42470941 |
| 56 | MAPK13 | 0.41805018 |
| 57 | MATK | 0.41795560 |
| 58 | PLK4 | 0.40029019 |
| 59 | CAMK1D | 0.38940995 |
| 60 | MYLK | 0.37032482 |
| 61 | PIK3CA | 0.36978066 |
| 62 | MAP3K12 | 0.36395532 |
| 63 | MAP2K4 | 0.35934273 |
| 64 | PIK3CG | 0.35596242 |
| 65 | STK38L | 0.33875702 |
| 66 | DAPK1 | 0.33460423 |
| 67 | PRKACG | 0.32862719 |
| 68 | CAMK1G | 0.32749667 |
| 69 | PRKCZ | 0.30896817 |
| 70 | MAP3K3 | 0.30484779 |
| 71 | CDC42BPA | 0.29775377 |
| 72 | JAK3 | 0.28502262 |
| 73 | ZAP70 | 0.28247313 |
| 74 | ZAK | 0.28048751 |
| 75 | MAP3K1 | 0.27613053 |
| 76 | PKN1 | 0.26494015 |
| 77 | MARK2 | 0.26122926 |
| 78 | MET | 0.23862734 |
| 79 | HIPK2 | 0.23588400 |
| 80 | PRKCA | 0.23013210 |
| 81 | CAMKK2 | 0.22399461 |
| 82 | IGF1R | 0.21944418 |
| 83 | TRIM28 | 0.21685621 |
| 84 | MAP3K5 | 0.20866023 |
| 85 | CAMK2A | 0.20660303 |
| 86 | RET | 0.19954734 |
| 87 | ITK | 0.17919848 |
| 88 | PAK1 | 0.17676066 |
| 89 | TNK2 | 0.17272835 |
| 90 | PRKCB | 0.17021499 |
| 91 | CDK4 | 0.16750823 |
| 92 | NTRK1 | 0.16746261 |
| 93 | TAF1 | 0.15788716 |
| 94 | OXSR1 | 0.14752197 |
| 95 | TGFBR1 | 0.14438871 |
| 96 | ATR | 0.12626004 |
| 97 | EIF2AK1 | 0.12490195 |
| 98 | MAPK4 | 0.12072254 |
| 99 | RPS6KL1 | 0.11997047 |
| 100 | RPS6KC1 | 0.11997047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.60630361 |
| 2 | * Olfactory transduction_Homo sapiens_hsa04740 | 3.35459871 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.72099005 |
| 4 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.51535089 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.41524818 |
| 6 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.39844776 |
| 7 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 2.24958198 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.06521951 |
| 9 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.06076646 |
| 10 | Platelet activation_Homo sapiens_hsa04611 | 1.98341659 |
| 11 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.95120933 |
| 12 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.89820989 |
| 13 | ABC transporters_Homo sapiens_hsa02010 | 1.89414908 |
| 14 | Long-term depression_Homo sapiens_hsa04730 | 1.87147144 |
| 15 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.86786965 |
| 16 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.86046305 |
| 17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.79962864 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76748662 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76594624 |
| 20 | Circadian rhythm_Homo sapiens_hsa04710 | 1.68391517 |
| 21 | Morphine addiction_Homo sapiens_hsa05032 | 1.56068448 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.53443223 |
| 23 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.53226758 |
| 24 | Phototransduction_Homo sapiens_hsa04744 | 1.47899445 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46630470 |
| 26 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.45285981 |
| 27 | Salivary secretion_Homo sapiens_hsa04970 | 1.34766045 |
| 28 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.27357908 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26042417 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.22346011 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.21077468 |
| 32 | Circadian entrainment_Homo sapiens_hsa04713 | 1.20571287 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.19462596 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.17110264 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.12004249 |
| 36 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.10750334 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.10267740 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06622316 |
| 39 | Basal transcription factors_Homo sapiens_hsa03022 | 1.06145976 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.03015863 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.01735272 |
| 42 | GABAergic synapse_Homo sapiens_hsa04727 | 0.97212597 |
| 43 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.96082001 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.92260369 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91213503 |
| 46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.87737930 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 0.87287616 |
| 48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86823099 |
| 49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85141819 |
| 50 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.82547164 |
| 51 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.81570906 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.77715663 |
| 53 | Allograft rejection_Homo sapiens_hsa05330 | 0.77579583 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77575545 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77331361 |
| 56 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.76485108 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75567801 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74134013 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72644222 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70981273 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68406965 |
| 62 | Insulin secretion_Homo sapiens_hsa04911 | 0.67792765 |
| 63 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65062770 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64340685 |
| 65 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62228913 |
| 66 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.60983077 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.59687268 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 0.59193002 |
| 69 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56092392 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54625281 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54173183 |
| 72 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.53940445 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.53762515 |
| 74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.53474286 |
| 75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52857762 |
| 76 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52596077 |
| 77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51183456 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.49504737 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43892786 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.43834719 |
| 81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.43005814 |
| 82 | Homologous recombination_Homo sapiens_hsa03440 | 0.42482832 |
| 83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42017893 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40734290 |
| 85 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38017595 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.37313399 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.36820595 |
| 88 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.36746166 |
| 89 | Alcoholism_Homo sapiens_hsa05034 | 0.35134328 |
| 90 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32938234 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32862953 |
| 92 | Taste transduction_Homo sapiens_hsa04742 | 0.32050845 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31557739 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30333593 |
| 95 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.30255603 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28218859 |
| 97 | Peroxisome_Homo sapiens_hsa04146 | 0.28045071 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26583878 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26348185 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26106301 |

